-
Lucid Diagnostics completes $70 million initial public offering
20 Oct 2021 01:27 GMT
… , has completed a $70 million initial public offering (IPO) on the Nasdaq Global Market … ; at the IPO price, the company’s estimated … Markowitz, the Ingalls Professor of Cancer Genetics and Medicine at the School …
-
Black Diamond Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
03 Feb 2020 21:30 GMT
… announced the closing of its initial public offering of 12,174,263 shares … upon a deep understanding of cancer genetics, protein structure and function, and …
-
Black Diamond Therapeutics Announces Pricing of Initial Public Offering
30 Jan 2020 00:33 GMT
… announced the pricing of its initial public offering of 10,586,316 shares … of common stock at the initial public offering price.
J.P. Morgan Securities … upon a deep understanding of cancer genetics, protein structure and function, and …
-
MDNA Life Sciences Starts IPO Rollout
08 Aug 2022 18:19 GMT
… head of sales operations for Cancer Genetics and led the N. America … Hutton. Commentary About MDNA’s IPO MDLS is seeking public capital … is the sole underwriter and IPOs led by the firm over … provide a final opinion. Expected IPO Pricing Date: To be announced …
-
Eli Lilly to buy Loxo Oncology for $8 billion in huge bet on cancer genetics - STAT
07 Jan 2019 14:28 GMT
Eli Lilly, the Indianapolis-based drug giant, said Monday that it will purchase Loxo Oncology, a tiny startup, for $8 billion in cash to gain access to the company’s cancer medicines, one of which is on the market.
The deal price of $235 per share …
-
Cancer Genetics Appoints Renowned Biotech Entrepreneur Dr. Thomas F. Widmann to its Board of Directors
27 Nov 2017 13:00 GMT
… Actelion’s highly successful IPO and secondary offering, … Welsh, MD. ABOUT CANCER GENETICS
Cancer Genetics Inc. is a leader … www.cancergenetics.com
Twitter: @Cancer_Genetics
Facebook: www.facebook.com … statements pertaining to Cancer Genetics Inc.’s future …
-
Cancer Genetics, Inc. Announces Pricing of Initial Public Offering of 600,000 Shares of Common Stock
05 Apr 2013 14:47 GMT
… announced the pricing of its initial public offering of 600,000 shares … The gross proceeds to Cancer Genetics from the initial public offering are expected to be … offering expenses payable by Cancer Genetics. Cancer Genetics has granted the representative …
-
The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO
29 Jan 2021 14:05 GMT
… .26 in after-hours trading.
Cancer Genetics Inc (NASDAQ: CGIX) said it … estimates)
IPOs
Switzerland-based NLS Pharmaceutics Ltd. priced its initial public offering of 4 …
-
Lung cancer tester Biodesix makes preliminary IPO filing
02 Oct 2020 21:26 GMT
… -cancer genetics tester Biodesix Inc. has filed a preliminary prospectus for an initial public offering … , filed for a $100 million IPO in June before accepting a … the strongest performers in the IPO market this year, specifically because …
-
IPO Update: Lantern Pharma Readies $25 Million IPO
12 May 2020 21:37 GMT
… previously president and CEO of Cancer Genetics (CGIX). Below is a … for life science IPOs. Assuming a successful IPO at the midpoint … value. Most typical biopharma IPOs have been in the range … U.S. IPOs with IPO Edge research.
Members of IPO Edge get the …
About
© 1995-2025